[INQ. NO. 2304E05] CUREXO, Inc., the No. 1 surgical medical robot
company in Korea, is currently developing and selling three types of surgical medical robots. Korea’s first spinal surgery robot ‘CUVIS-spine,’ artificial joint surgery robot ‘CUVIS-joint,’ and gait rehabilitation robot ‘Morning Walk.’
Among them, CUVIS-joint was used for 4,000 surgeries at home and
abroad last year, and Morning Walk proved its clinical value by its use in performing 40,000 treatments.
CUVIS-joint, which has already been launched in the Indian market, is also progressing well with plans to enter the U.S. market. This product is a system combined with ‘T-Plan,’ which is artificial joint surgery planning software of Think Surgical (TSI), a U.S. affiliate. It is scheduled to be sold in the U.S. market from 2024 under the product name ‘TMAX.’ The goal is to apply for approval from the U.S. Food and Drug Administration (FDA) in the first half of this year and receive approval at the end of this year. CUREXO will be in charge of system development and production, and TSI will be in charge of marketing and sales, including the FDA approval process.
According to industry estimates, the size of the surgical robot market reached about 12 trillion won last year. Of these, 76% were laparoscopic surgical robots. It is expected that the share of orthopedic and neurosurgery robots will increase to 30% while growing to the 20 trillion won level by this year.
Striving to develop AI surgical robots
CUREXO has recently signed a partnership with Microsoft (MS) of the United States, which has driven the artificial intelligence (AI) Chat GPT craze, to develop AI surgical robots.
It is expected that a method in which an AI robot will be developed for the first time in Korea that will be responsible for a significant part of surgery, from calculating a surgical plan to cutting, even with just one X-ray or computed tomography (CT) picture
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods
Korean-Electronics.com 